|
Originally published In Press as doi:10.1074/jbc.M103364200 on October 4, 2001
J. Biol. Chem., Vol. 276, Issue 50, 47575-47582, December 14, 2001
A Potential Role for Human Cohesin in Mitotic Spindle Aster
Assembly*
Heather C.
Gregson ,
John A.
Schmiesing ,
Jong-Soo
Kim ,
Toshiki
Kobayashi §,
Sharleen
Zhou¶, and
Kyoko
Yokomori
From the Department of Biological Chemistry, College
of Medicine, University of California, Irvine, California 92697-1700 and the ¶ Department of Molecular and Cell Biology, Howard Hughes
Medical Institute, University of California,
Berkeley, California 94720-3202
Received for publication, April 16, 2001, and in revised form, August 30, 2001
 |
ABSTRACT |
The cohesin multiprotein complex containing SMC1,
SMC3, Scc3 (SA), and Scc1 (Rad21) is required for sister chromatid
cohesion in eukaryotes. Although metazoan cohesin associates
with chromosomes and was shown to function in the establishment of
sister chromatid cohesion during interphase, the majority of cohesin
was found to be off chromosomes and reside in the cytoplasm in
metaphase. Despite its dissociation from chromosomes, however,
microinjection of an antibody against human SMC1 led to disorganization
of the metaphase plate and cell cycle arrest, indicating that human
cohesin still plays an important role in metaphase. To address
the mitotic function of human cohesin, the subcellular localization of
cohesin components was reexamined in human cells. Interestingly, we
found that cohesin localizes to the spindle poles during mitosis and interacts with NuMA, a spindle pole-associated factor required for
mitotic spindle organization. The interaction with NuMA persists during
interphase. Similar to NuMA, a significant amount of cohesin was found
to associate with the nuclear matrix. Furthermore, in the absence of
cohesin, mitotic spindle asters failed to form in vitro.
Our results raise the intriguing possibility that in addition to its
well demonstrated function in sister chromatid cohesion, cohesin may be
involved in spindle assembly during mitosis.
 |
INTRODUCTION |
Proper chromosome segregation in mitosis is essential for the
maintenance of chromosome integrity. Sister chromatid cohesion, which
ensures the pairing of the two sister chromatids, is a prerequisite for
proper chromosome segregation at anaphase. Cohesin is a multiprotein complex required for sister chromatid cohesion in eukaryotes. Cohesin
was first characterized in Saccharomyces cerevisiae, which is composed of two structural maintenance of
chromosome (SMC)1
family proteins, Smc1p and Smc3p, as well as the non-SMC components Scc1 and Scc3p (Refs.1-3 and see review in Ref. 4). A similar complex
was identified in Schizosaccharomyces pombe,
Xenopus, and humans (5-7). In S. cerevisiae,
cohesin functions in both the establishment and maintenance of sister
chromatid cohesion from S phase to metaphase (1, 2). Consistently,
cohesin in S. cerevisiae stays associated with chromosomes
from the late G1 phase until the onset of anaphase (3).
Scc1p is a homolog of Rad21 identified earlier in S. pombe
(8). Proteolytic cleavage of Scc1p by the cysteine protease separin,
which is indirectly promoted by the anaphase-promoting complex
at the end of metaphase, is responsible for the destruction of cohesin
and the initiation of sister chromatid segregation in anaphase (9). A
similar observation was made in S. pombe, although S. pombe cohesin stays associated with chromosomes throughout the
cell cycle (7). Studies of S. cerevisiae identified the
in vivo binding sites of cohesin on the chromosome arms at
estimated intervals of 13 kb with the highest concentration at the
centromeric regions (10-12). Similar centromeric clustering of cohesin
was also observed in S. pombe (7).
In metazoans, the protein composition of cohesin is conserved, although
there are two Scc3p homologs, stromal antigen 1 (SA1) and 2 (SA2), forming separate cohesin complexes in the cell (5, 6). Interestingly, chromosomal association of cohesin in metazoans differs from that of yeast cohesin. In a Xenopus oocyte
cell-free system, depletion of cohesin during interphase prior to
entering mitosis inhibited subsequent mitotic cohesion of sister
chromatids, suggesting that the complex is required for establishing
cohesion following DNA replication (13). In contrast to S. cerevisiae, however, metazoan cohesin was found to dissociate from
chromosomes prior to entering mitosis (6, 13, 14). Therefore, it is unclear how sister chromatid cohesion is maintained during metaphase. A
recent study using Myc-tagged human RAD21 (hRAD21/Scc1) suggested that
at least a small amount of hRAD21 is in the centromeric regions during
metaphase and is subject to a similar proteolytic cleavage as in yeast
(15). Similar localization was reported with the endogenous hRAD21
protein (16). In Xenopus, SA1 was shown to localize between
two sister chromatids in vitro, suggesting that a low amount
of cohesin may continue to associate with metaphase chromosomes in
higher eukaryotes, reminiscent of buttons on a jacket securing a few
critical regions of sister chromatids together (5). It was reasoned
that the chromosomes of higher eukaryotes must condense to a higher
level and that the presence of too many cohesin molecules may
interfere with efficient chromosome condensation. However, the observed
localization represents a very minor population of cohesin (estimated
to be ~5%) (5), and the role of metazoan cohesin in metaphase
cohesion has not been clearly demonstrated. Furthermore, it is not
known whether cytoplasmic cohesin plays any role in mitosis.
Despite the fact that the majority of cohesin is in the cytoplasm in
mitotic cells, we previously showed that the injection of an antibody
specific for hSMC1 into human mitotic cells blocked the progression of
metaphase and led to disorganization of the metaphase plate, suggesting
a role for cohesin in mitosis (14). However, its mechanism was unknown.
The same antibody failed to detect any hSMC1 at the interface between
the two sister chromatids, which would be the predicted site for
cohesin localization. To further address the mitotic role of human
cohesin, we characterized the human cohesin complex containing
hSMC1, hSMC3, hRAD21, and SA1/SA2 and performed detailed immunostaining
and biochemical analyses of cohesin subcellular localization in human
cells. Here we report that cohesin localizes at the spindle poles
during mitosis and interacts with the nuclear mitotic apparatus protein
(NuMA) and more weakly but specifically with dynein and -tubulin.
Similar to NuMA, cohesin also interacts with the nuclear matrix during interphase. Further analysis showed that cohesin is required for mitotic spindle aster assembly in vitro. Our studies suggest
a novel function of cohesin in mitotic spindle organization.
 |
EXPERIMENTAL PROCEDURES |
Cell Lines and Cell Culture--
HeLa cells were grown in
Dulbecco's modified Eagle's medium (Sigma) supplemented with 10%
fetal bovine serum, L-glutamate, and
penicillin/streptomycin.
Synchronization of HeLa Cells--
HeLa cells were synchronized
to the S and G2 phases by a double thymidine block, and to
G1 phase by an additional nocodazole treatment as
previously described (17). The DNA content profile from cells
synchronized at each cell cycle stage was analyzed by a FACSCalibur (BD
PharMingen). For FACS analysis, cells were fixed in 75% ethanol at
80 °C. Cells were then stained with 5 µg/ml propidium iodide in
the presence of 300 µg/ml RNase A.
Antibodies--
Rabbit polyclonal antibodies were raised against
recombinant polypeptides expressed in Escherichia coli
corresponding to the middle and C-terminal domains of hSMC1 (amino
acids 402-894 and 888-1233, respectively), the N-terminal domain of
hSMC3 (amino acids 1-303), the N- and C-terminal domains of human SA1
designated as SA1N and SA1C (amino acids 1-230 and 1028-1258,
respectively), the C-terminal domain of hRAD21 (amino acids 286-543),
and the N terminus of NuMA (amino acids 1-307). Antibodies were
affinity-purified with the same recombinant polypeptides purified and
cross-linked to Affi-Gel (Bio-Rad) or expressed as glutathione
S-transferase fusion proteins crosslinked to glutathione
beads (Amersham Pharmacia Biotech.) with dimethyl pimelimidate (Sigma).
Anti-Xenopus RAD21 (XRAD21) peptide antibody against the conserved
C-terminal domain was kindly provided by Dr. Tatsuya Hirano at Cold
Spring Harbor Laboratory (13). Anti-DNA ligase III antibody was
generously provided by Dr. Thomas Lindahl at the Imperial Cancer
Research Fund, United Kingdom. Anti-BRCA1 antibody was kindly
provided by Dr. Ramin Shiekhattar at the Wistar Institute,
Philadelphia, PA. Mouse monoclonal antibodies specific for NuMA
(Calbiochem), for the dynein 70-kDa subunit (Sigma), and for
-tubulin (Sigma) were also used for colocalization studies and
Western blot analyses. Secondary antibodies included goat anti-rabbit
IgG antibody conjugated with Cy3 (Jackson Laboratory), and donkey
anti-mouse IgG antibody conjugated with fluorescein (Vector Laboratory).
Immunoprecipitation and Western Blot Analysis--
Large
scale immunoprecipitation and peptide sequencing protocols used for the
identification of hRAD21 are similar to those described (14).
Coimmunoprecipitation was performed as previously described (14). The
immunoprecipitated proteins were analyzed by SDS-PAGE and silver
staining or transferred to nitrocellulose membrane and analyzed by
Western blotting as described previously (14, 17). Western blots were
developed by either colorimetric reaction (Promega) or enhanced
chemiluminescence (ECL kit, Amersham Pharmacia Biotech).
Sucrose Gradient Ultracentrifugation--
To estimate
sedimentation coefficient values, crude HeLa cell nuclear extracts in
0.4 M salt were subjected to 5-30% sucrose gradient
centrifugation at 155,000 × g for 15 h with a
SW50.1 rotor (Beckman Instruments). Each fraction was trichloroacetic acid-precipitated and analyzed by SDS-PAGE and Western blotting. Standard proteins bovine serum albumin (4.6 S), catalase (11.3 S), and
ferritin (16.5 S) were run in the same gradient multiple times to
confirm the linearity of the gradient.
Immunofluorescent Staining Analysis--
Immunofluorescent
staining of cells was performed as described previously (14, 17).
Immunofluorescent image analysis was performed using a Zeiss Axioplan 2 microscope with a Photometrics Sensys Camera. J/C Cittert iterative
digital deconvolution was performed using the Zeiss KS 300 program.
Alternatively, the analysis was carried out using an Olympus IX70 with
the MagnaFire digital charge-coupled device camera system.
Cell Extraction--
In situ cell extraction was
performed essentially as described (17). Cell extraction was performed
either in situ on coverslips for immunostaining analysis or
in test tubes for Western blot analysis. The same number of cells were
used for the extraction in test tubes. Briefly, the cells were washed
with phosphate-buffered saline and cytoskeleton (CSK) buffer (10 mM Pipes, pH 7.0, 100 mM NaCl, 300 mM sucrose, and 3 mM MgCl2). Cells
were extracted using CSK buffer with 0.5% Triton-X for 5 min at
4 °C to remove soluble cytoplasmic proteins. Cells were then treated
with an extraction buffer (42.5 mM Tris-HCl, pH 8.3, 8.5 mM NaCl, 2.6 mM MgCl2, 1% Tween
20, and 0.5% sodium deoxycholate) for 5 min at 4 °C to remove
cytoskeletal proteins. The cells were subsequently treated with CSK
buffer (containing 2 mM CaCl2 and 2 mM MgCl2), 0.5% Triton X, and 100 µg/ml
DNase I (Worthington) for 30 min at 37 °C. The cells were then
washed with 0.25 M ammonium sulfate in CSK. In a control
sample, cells were treated with the same buffer without DNase I. Between each step, cells were centrifuged at 3,000 rpm, and the
supernatant was recovered as the CSK extraction and DNase fractions.
The pellet was washed twice in CSK buffer containing 0.5% Triton X,
resuspended in SDS sample buffer, and subjected to SDS-PAGE and Western
blot analysis. The experiments were repeated at least three times. The
intensities of the protein bands in the Western blots from at least
three experiments were quantitated by NIH IMAGE.
In Vitro Mitotic Aster Assembly Assay--
The in
vitro aster assembly assay was performed using the protocol of
Gaglio et al. (18-20). Briefly, HeLa cells were
synchronized at mitosis as described above. Mitotic cells were
collected by shake-off and incubated with 20 µg/ml cytochalasin B. Cells were then washed with phosphate-buffered saline and resuspended
in KHM buffer (78 mM KCl, 50 mM Hepes, pH 7.0, 4 mM MgCl2, 2 mM EGTA, 1 mM dithiothreitol, and 0.2 mM
4-(2-aminoethyl)-benzenesulfonyl fluoride) containing
cytochalasin B at a concentration of ~3 × 107
cells/ml. Cells were Dounce-homogenized, and the crude extract was
subjected to ultracentrifugation at 100,000 × g for 15 min. at 4 °C. The supernatant was collected, and a fraction
of it was subjected to immunodepletion. Approximately 10-20 µg of
either preimmune IgG purified with protein A beads, antigen
affinity-purified anti-hSMC1, anti-hSMC3, anti-SA-1N, anti-hRAD21, or
anti-BRCA1 antibody were coupled to protein A beads and incubated with
20 µl of mitotic extracts for 45 min at 4 °C. The beads were spun down, the supernatants were collected, and the depletion process was
repeated. The final supernatants were passed through empty spin columns
to remove any remaining beads. The supernatants were incubated for 60 min at 30 °C in the presence of 2.5 mM ATP and 10 µM taxol for the in vitro aster assembly.
After the reaction, a small portion of each sample was dropped onto a
coverslip and subjected to immunofluorescent staining with an antibody
specific for -tubulin (Sigma) or co-stained with anti-NuMA antibody.
The remaining portions of the samples were used for Western blot
analysis to detect the presence of hSMC1, -tubulin, and NuMA.
Mitotic asters assembled in a control reaction without immunodepletion were sedimented at 10,000 × g for 15 min at 4 °C as
described (18), and the presence of NuMA and hSMC1 in the supernatant and pellet was analyzed by Western blot.
 |
RESULTS |
The hSMC1-hSMC3 Heterodimer Is in the Cohesin Complex in Both
Interphase and Mitosis--
Previously, we identified the stable
heterodimeric complex of hSMC1 and hSMC3 in human cells (14).
Reciprocal coimmunoprecipitation of the endogenous hSMC1 and hSMC3
proteins from HeLa nuclear extracts indicates that the SMC molecules
are engaged in a highly stable heterodimeric complex resistant to a
mild denaturant (2 M guanidine) in an equimolar ratio in
the absence of any other associated proteins (Fig.
1A). Because microinjection of
an antibody against hSMC1 blocked the progression of metaphase in the
previous study (14), we first wanted to determine whether hSMC1-hSMC3
is still in the cohesin complex in mitotic cells. Under the
coimmunoprecipitation condition, including a 1 M salt wash,
human cohesin containing hRAD21 and SA1/SA2 is coimmunopurified with
antibody specific for hSMC1 (Fig. 1, B and C).
The association of hRAD21 and SA1/SA2 with hSMC1-hSMC3, although
resistant to the 1 M salt wash, is sensitive to 2 M guanidine unlike the interaction between hSMC1 and hSMC3
(Fig. 1A). Therefore, an hSMC1-hSMC3 heterodimer is a core
subunit of cohesin, and hRAD21 and SA1/SA2 associate with it. The
presence of hRad21 was also confirmed by peptide sequence analysis of
the 115-kDa protein corresponding to hRAD21 (KINHL (amino acid 210) and
KGGEADNLDEFLK (amino acid 410)) (GenBankTM accession number
D38551) (21). The amounts of hRAD21 and SA1/SA2
coimmunoprecipitated with anti-hSMC1 antibody are comparable between S-
and M-phase extracts, indicating that hSMC1-hSMC3 is part of
cohesin during both S phase and mitosis (Fig. 1, B and C). Anti-SA1N antibody (directed against the N terminus of
SA1) detected both SA1 and SA2, whereas anti-SA1C (against the C
terminus) antibody detected a single protein species (SA1), consistent
with the different C-terminal sequences in SA1 and SA2 (Fig. 1,
C and D) (5). Because bovine SMC1 and SMC3 was
found to be part of the recombination repair complex, RC-1 (22), the
presence of DNA ligase III in the hSMC1 coimmunoprecipitation was also
examined. DNA ligase III was not detected in our coimmunoprecipitation
from HeLa nuclear extracts, indicating that the RC-1 repair complex represents a very minor complex in human cells (data not shown). Taken
together, these results indicate that hSMC1-hSMC3 is in the cohesin
complex in both S phase and mitotic cells at similar levels. The
specificity of the antigen affinity-purified antibodies specific for
hSMC1, hSMC3, hRAD21, and SA1N and SA1C was demonstrated by Western
blot analysis using crude HeLa extracts from various cell cycle stages
(14) as well as mitotic whole cell extracts (Fig. 1D).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 1.
Human cohesin, containing a hSMC1/hSMC3
heterodimer, SA1/SA2, and hRAD21 is a major complex containing
hSMC1/hSMC3. A, reciprocal immunoprecipitation of the
hSMC1/hSMC3 heterodimeric complex. Antibodies specific for hSMC1 and
hSMC3 were used to immunoprecipitate the endogenous SMC proteins from
HeLa nuclear extracts. Immunoprecipitates were washed with 2 M guanidine-HCl, and proteins remaining on antibody beads
were visualized by silver staining. The polypeptides corresponding to
hSMC1 and hSMC3 are indicated. The antibodies used for
immunoprecipitation are indicated at the top.
IgH, IgG heavy chain; M, molecular weight marker.
B, coimmunoprecipitation of hRAD21 with anti-hSMC1 antibody.
HeLa extracts from S phase (S) and M phase (M)
were immunoprecipitated with an anti-hSMC1 antibody and washed with 1 M salt. The precipitated materials were subjected to
Western blot analysis using an antibody specific for RAD21.
Lanes 2 and 4 are input extracts
(input) and lanes 1 and 3 are immunoprecipitated polypeptides (IP) as indicated at the
top. C, coimmunoprecipitation of SA1/SA2 with an
anti-hSMC1 antibody. The experiments were performed similar to
B but probed with an anti-SA1N antibody. Lanes
1 and 2 are input extracts (input),
and lanes 3 and 4 are the proteins
immunoprecipitated (IP) with anti-hSMC1 antibody. Cell cycle
stages of the extracts (S, S phase; M, M phase)
are indicated at the top. Two protein species detected by an
anti-SA1N antibody are indicated as SA1 and SA2.
D, Western blot analysis of whole cell extracts from mitotic
HeLa cells. The specificity of antibodies against the middle domain and
the C-terminal domain of hSMC1 (lanes 1 and
2), the N terminus of hSMC3 (lane 3),
SA1N (which detects both SA1 and SA2), and SA1C is shown. These
antibodies were used in subsequent experiments.
|
|
Cohesin Localizes to Spindle Poles during Mitosis and Interacts
with NuMA, Dynein, and -Tubulin--
Using the above antibodies, we
next tested whether cohesin localizes to specific sites in mitotic
cells. We performed a partial in situ extraction of
soluble proteins for this purpose (CSK extraction, see "Experimental
Procedures"). We found that a subpopulation of cohesin localizes to
spindle poles in mitotic cells, both in metaphase and anaphase (Fig.
2). Spindle pole staining was detected using antibodies against hSMC1 (produced in two different rabbits), hSMC3, SA1N (which also recognizes SA2), and SA1C (Fig. 2 and data not
shown). The corresponding preimmune antisera and antigen-depleted antibodies did not show spindle pole staining, indicating that the
staining is antigen-specific (data not shown). The spindle pole
localization was verified by co-staining with both - and -tubulin
antibodies (data not shown). Thus, cohesin is present at spindle poles
during mitosis.

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 2.
Human cohesin localizes to spindle poles in
mitosis. Immunofluorescent staining of spindle poles with
antibodies specific for hSMC1 and SA1N. DNA was visualized by DAPI
staining. Cells were pre-extracted with CSK buffer. Mitotic spindle
poles are indicated by white arrowheads. In
merged images (panels 3 and 6), SA1 or
hSMC1 (red) and DAPI (cyan) are shown.
|
|
Based on the above results, we next tested for potential interactions
of cohesin with proteins that are known to localize to the spindle
poles. We found that cohesin specifically interacts with NuMA. NuMA
plays an important role in mitotic spindle organization in
vivo and in vitro (20, 23). NuMA interacts with
dynein/dynactin and -tubulin and is targeted to the mitotic spindle
poles by the dynein/dynactin-dependent transport mechanism
(23, 24). An anti-hSMC3 antibody co-precipitated NuMA from mitotic HeLa extracts, which is resistant to a 1 M salt wash (Fig.
3, lane 4). Neither
the protein A beads alone nor the preimmune antibody precipitated NuMA
(Fig. 3, lanes 2 and 3). Because NuMA
interacts with dynein and -tubulin, cohesin interaction with these
proteins was also tested. Anti-hSMC3 antibody coimmunoprecipitated
dynein and -tubulin from mitotic extracts (Fig. 3, lanes
5-15). No dynein or -tubulin was precipitated with
protein A beads alone or with preimmune IgG (lanes
6, 7, 9, 10, 13,
and 14). In contrast to the NuMA interaction, however, these
interactions were entirely sensitive to 1 M salt,
indicating that the interaction is weaker and may be indirect (Fig. 3,
lanes 8 and 15).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 3.
The hSMC3 protein interacts with NuMA,
dynein, and -tubulin in mitosis. Western
blot analyses of anti-hSMC3 coimmunoprecipitation probed with
anti-NuMA, anti-dynein, and anti- -tubulin antibodies. HeLa mitotic
extracts were immunoprecipitated with an anti-hSMC3 antibody, and the
precipitated material was subjected to multiple low salt washes and
eluted with 1 M salt followed by 2 M
guanidine-HCl. As indicated at the bottom, proteins eluted
by each treatment (1 M salt and 2 M
guanidine-HCl) were trichloroacetic acid-precipitated and subjected to
Western blot analysis. As indicated at the top, protein A
beads without an antibody (lanes 2, 6,
9, and 13) or preimmune IgG on beads
(lanes 3, 7, 10, and
14) were incubated with the same extract and were treated in
an identical manner. Lanes 1, 5, and
12, an input extract as a positive control for the Western
blot.
|
|
The interaction of NuMA and cohesin was also examined in S phase (Fig.
4, A and B).
Anti-hSMC1 antibody co-precipitated NuMA from both S and M phase
extracts (Fig. 4A, lanes 5 and
6). In contrast, CNAP1 (hCAP-D2), a component of the
condensin complex that is present abundantly in the mitotic cytoplasm
as well as on chromosomes (17), failed to co-precipitate with hSMC1,
demonstrating the specificity of the coimmunoprecipitation (Fig.
4A, lanes 9-12). Consistently, NuMA
reciprocally coimmunoprecipitated hSMC1 from both S- and M-phase
extracts (Fig. 4B). Furthermore, SA1/SA2, hRAD21, and NuMA
co-precipitated each other in a 1 M salt-resistant manner
(data not shown). Interestingly, among the multiple species of NuMA,
only a subspecies of NuMA appears to tightly interact with cohesin
(Fig. 3, compare lanes 1 and 4; Fig.
4A, compare lanes 1, 2,
5, and 6). The one that preferentially interacts
with cohesin in a 1 M salt-resistant manner differs between
S and M phases, a faster migrating species in S phase and a slower one in M phase (Fig. 4A, lanes 5 and
6). NuMA was shown to be hyperphosphorylated in a
mitosis-specific manner by cdc2 kinase, which results in slower
migration of the protein in SDS-PAGE (25). This phosphorylation was
shown to be critical for the proper targeting of NuMA to spindle microtubules and is thus important for the function of NuMA in spindle
organization (26). Therefore, our results strongly suggest that cohesin
specifically interacts with NuMA localized at the spindle structure in
mitosis (Fig. 3, lane 4; Fig. 4A,
lane 6). However, the tight interaction was only
seen with a subpopulation of each form of NuMA (Fig. 4A,
compare 1 M salt and guanidine eluate), and the peak of
NuMA in sucrose density gradient centrifugation did not coincide with
that of cohesin, indicating that NuMA is not a component of cohesin
(Fig. 4C). Taken together, the identified interaction of
cohesin with the known spindle pole-associated protein NuMA, as well as
weaker but specific interactions with dynein and -tubulin, further
supports the observed localization of cohesin at the spindle poles.

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 4.
Human cohesin interacts with NuMA in both
mitosis and interphase. A, Western blot analysis of
anti-hSMC1 coimmunoprecipitation. HeLa extracts were immunoprecipitated
with an anti-hSMC1 antibody and eluted with 1 M salt
followed by 2 M guanidine-HCl. In addition to an input
extract (positive control) (lanes 1,
2, and 9), 1 M salt (lanes
3, 4, and 10), 2 M
guanidine eluate (lanes 5, 6, and
11), and the remaining beads (lanes 7,
8, and 12) as indicated at the top
were subjected to Western blot analysis with anti-NuMA antibody
(lanes 1-8) and anti-CNAP1 antibody
(lanes 9-12). S, S-phase extract;
M, M-phase extract; lanes 9-12,
M-phase extract coimmunoprecipitation. Preferentially co-precipitated
NuMA subspecies are indicated by arrowheads (lanes
5 and 6). B, reciprocal
immunoprecipitation of hSMC1 with anti-NuMA antibody. Lanes
1 and 4, input; lanes 2 and
5, immunoprecipitated with protein A beads alone (no
antibody); and lanes 3 and 6,
immunoprecipitated with anti-NuMA antibody as indicated at the
top. hSMC1 signal is indicated. Lanes 1-3,
mitotic extract; lanes 4-6, S phase extract. C,
Western blot analysis of fractions from 5 to 30% sucrose gradient
fractionation of crude HeLa S phase extract with antibodies specific
for hSMC1, NuMA, and RAD21. Fractions
1-11 represent the bottom to the top of the
gradient. Input, input extract. The peaks of hRAD21 and NuMA
are shown with brackets.
|
|
Human Cohesin Interacts with the Nuclear Matrix--
NuMA was
shown to associate with the nuclear matrix during interphase (27).
Because cohesin interacts with NuMA in interphase, we next tested
whether cohesin also associates with the nuclear matrix. We performed
serial extractions of cells on coverslips with detergent and DNase I to
visualize the proteins tightly associated with the nuclear matrix (28)
(Fig. 5). Completion of DNA digestion and
extraction was monitored by the disappearance of DAPI
staining (Fig. 5, panel 4). The results revealed that a
significant amount of hSMC1 associates tightly with the nuclear matrix.
Similar results were obtained with antibodies against hSMC3, hRAD21,
and SA1/SA2 (data not shown). No significant difference was observed
between the cells extracted with or without high salt after DNase I
treatment. Thus, it is unlikely that the observed nuclear matrix
localization is due to the precipitation of cohesin proteins. The
nuclear matrix association of cohesin contrasts with the observation
noted with condensin, the other SMC-containing complex, the nuclear
localization of which was sensitive to DNase I treatment (17).

View larger version (82K):
[in this window]
[in a new window]
|
Fig. 5.
Human cohesin associates with the nuclear
matrix during interphase. Immunofluorescent staining analysis of
hSMC1 after serial in situ extraction of HeLa cells. The
top panels show the localization of hSMC1 after
each treatment using anti-hSMC1 antibody, and the bottom
panels show DAPI. Each treatment is indicated at the
top. The untreated panel shows the localization of hSMC1
before the extraction treatment (panel 1). Cells were
treated with CSK and extraction buffers that remove soluble cytoplasmic
proteins (panels 2 and 3). The cells were then
treated with DNase I to remove DNA (panel 4).
|
|
We next performed the same experiments in a test tube. These
extractions with salt and detergent as well as DNase I removed soluble
cytoplasmic and nuclear proteins as well as DNA-associated proteins in
a stepwise manner, leaving proteins that tightly associate with the
nuclear matrix. Eluted material from each step was subjected to Western
blot analysis with anti-hSMC1 antibody (Fig.
6A). We found three
populations of hSMC1. The first population of hSMC1 eluted in the
soluble fractions (Fig. 6A, CSK and
Extraction, lanes 2 and 3).
A second population of hSMC1 was co-eluted with DNA after DNase I
digestion (Fig. 6A, lane 4). This
elution was dependent on DNase I (Fig. 6A, lane
9). A third population of hSMC1 remained associated with the
nuclear matrix (Fig. 6A, lane 5). In
the same experiments, cytoplasmic dynein was removed in the first
extraction while NuMA remained in the last nuclear matrix fraction,
consistent with their subcellular localization (Fig. 6B).
When extractions from S and G2 phase cells were
compared, we found that cohesin dissociation from chromosomes is
initiated in the G2 phase. In G2 phase,
significantly less hSMC1 and hSMC3 were found in the DNA fraction
compared with S phase, indicating that they are dissociating from
chromosomes during G2 phase (Fig. 6C, compare
lanes 4 and 9). Despite their
dissociation from chromosomes, however, both hSMC1 and hSMC3 remain
associated with the nuclear matrix (Fig. 6C, lane
10). Similar changes were observed with hRAD21 and SA1/SA2
(data not shown). Proper synchronization of cells to S and
G2 phases was confirmed by FACS analysis (Fig. 6D). Importantly, at 7 h after release from the
thymidine block (the prospective time point for G2 phase),
cells were clearly in interphase and not in prophase (Fig.
6E). Therefore, this is different from the results in
Xenopus embryos in which cohesin dissociation was shown to
occur in prometaphase (6). This may reflect the differences in cell
cycling between somatic and embryonic cells. Similar experiments with
G1-synchronized cells revealed that cohesin associates with
chromosomes, although at a lower level than in S phase, and with the
nuclear matrix (data not shown). These results indicate that the
association of cohesin with chromosomes is greatest in S phase and that
its dissociation from chromosome begins during G2 phase,
whereas a subpopulation remains associated with the nuclear matrix
throughout interphase.

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 6.
Association of human cohesin with chromosomes
and the nuclear matrix during S and G2 phases.
A, Western blot analysis of hSMC1 eluted by stepwise
extractions of S phase-synchronized HeLa cells. Each treatment is
indicated at the top. Lanes 6-10 show
samples that were treated in an identical manner to the samples in
lanes 1-5 except that lane 4 was
treated with DNase I and lane 9 was treated with the same
buffer without DNase I. B, Western blot analysis
of extractions of dynein and NuMA. The same extracted samples as in
A were analyzed with an antibody specific for dynein
(lanes 1-5) and NuMA (lanes 6-10). The proteins
are indicated by arrowheads. C, Western blot
analysis of cohesin components in the extracted samples from S- and
G2-phase cells. The same numbers of cells were treated in
an identical manner, using cells synchronized at S phase
(lanes 1-5) and G2 phase
(lanes 6-10). Each treatment is indicated at the
top. The same samples were probed with antibodies against
hSMC1 and hSMC3 as indicated. D, DNA content analysis of
HeLa cells after a double thymidine block. After the release from the
second thymidine block, cells were harvested at different time points
as indicated at the bottom and were subjected to FACS
analysis. The cells harvested at 2 and 7 h after the release from
thymidine correspond to S- and G2-phase cells used in
C, respectively. The histograms show the fluorescence signal
(x axis) versus the cell number (y
axis). E, cells at 7 h after the thymidine
release. Scale bar is 200 µm.
|
|
Cohesin Is Required for Mitotic Aster Assembly in
Vitro--
Localization of human cohesin at the spindle poles raises
the possibility that cohesin may function in the spindle organization during mitosis. To test this hypothesis, in vitro mitotic
aster assembly was performed using mitotic HeLa extracts, and the
effect of cohesin depletion was examined. In the control assay, NuMA and the major population of hSMC1 co-sedimented with assembled asters
consistent with the localization of cohesin at the spindle poles in
mitotic cells (Fig. 7A). The
extracts were immunodepleted with comparable amounts of
affinity-purified antibodies against hSMC1, hSMC3, SA1N, anti-BRCA1, or
purified preimmune IgG prior to the assembly reaction. Depletion of
hSMC1 from the extracts was confirmed by Western blot analysis (Fig.
7B). Anti-hSMC1-hSMC3, and SA1N antibodies efficiently
depleted hSMC1, whereas preimmune IgG and anti-BRCA1 failed to deplete
hSMC1. The in vitro aster assembly was carried out using
these immunodepleted extracts (Fig. 7C). Aster assembly is
ATP-dependent, because omitting ATP abolished any aster or
visible microtubule formation (Fig. 7C, panel 1). While preimmune IgG-and anti-BRCA1 depletion had no significant effect
on aster formation, depletion with the anti-hSMC1, anti-hSMC3, or
anti-SA1N antibody severely inhibited aster assembly. Occasionally, we
observed a few irregular, smaller asters and short microtubules (Fig.
7C, panels 4, 5, and
6). Anti-BRCA1 antibody was used for comparison because
BRCA1 was previously shown to localize to spindle poles and to play a
role in centrosome replication (29, 30). The control experiments with
preimmune IgG and anti-BRCA1 antibody demonstrate that the effect
of immunodepletion is cohesin-specific. The failure to assemble asters
in the cohesin-depleted extracts was apparently not due to indirect
depletion of NuMA or -tubulin, because the amounts of NuMA and
-tubulin were comparable in the control and experimental extracts as
assessed by Western blot analysis (Fig. 7D). This is
consistent with the observed in vivo interaction, in which
only a subpopulation of NuMA and -tubulin is involved in the
interaction with cohesin (Figs. 3 and 4).

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 7.
Human cohesin is required for mitotic
spindle aster assembly in vitro. A,
Western blot analysis of sedimented asters. After the normal aster
assembly reaction, assembled asters were sedimented and the pellet
(lane 1) and supernatant (lane 2) were subjected
to Western blot analysis with anti-NuMA or anti-hSMC1 antibody as
indicated. B, Western blot analysis of
immunodepleted HeLa mitotic extracts. Lane 1, input mitotic
extract. In lanes 2-7 antibodies used to deplete
the extracts are indicated at the top. Depleted extracts
were subjected to Western blot analysis with anti-hSMC1 as indicated on
the left. C, mitotic asters assembled in
vitro with immunodepleted extracts stained with anti- -tubulin
antibody. The same depleted extracts as in B were used for
the assembly reaction. Panel 1, aster assembly reaction
carried out in the absence of ATP. The antibodies used to deplete the
extracts are indicated at the top of each panel. A
representative aster for each depletion is shown. Scale bars
are 4 µm. D, Western blot analysis for the presence of
NuMA and -tubulin. Lane 1, input mitotic extract;
lane 2, anti-hSMC1-depleted extract; lane 3,
preimmuno-IgG-depleted extract. The extracts were probed with anti-NuMA
and anti- -tubulin antibodies as indicated.
|
|
To quantify the efficiency of aster assembly in immunodepleted
extracts, equal amounts of assembly reactions were spotted on
coverslips and co-stained for -tubulin and NuMA. In an in vitro assay, NuMA localizes to the polar end of the spindles at the core of the spindle aster, which can be used as a marker for the
mitotic aster (18-20). Mitotic extracts were immunodepleted with the
preimmune IgG, anti-hSMC1, or anti-hRAD21 antibody (Fig. 8). Similar to antibodies against other
cohesin components, anti-hRAD21 immunodepleted cohesin from mitotic
extracts (Fig. 8A, lane 3). Two
hundred -tubulin/NuMA-positive signals were examined on coverslips in areas randomly chosen under the microscope, and the number of asters
with normal morphology was counted (see Fig. 8 legend for details). The
average percentages of normal asters in depleted extracts are shown in
Fig. 8B. In preimmune-depleted extracts, normal asters
constituted more than 95% of -tubulin/NuMA-positive spots, whereas
cohesin-depleted extracts showed less than 10% normal asters (Fig.
8B). Fig. 9 shows the typical
assembly products by preimmune-depleted and cohesin-depleted extracts.
While clusters of asters with bright -tubulin and NuMA staining at
the central core were seen in the preimmune-depleted assembly similar
to the undepleted control, only a few irregular spindles with weak
-tubulin staining and associated NuMA signals were seen in
cohesin-depleted extracts. Taken together, these results indicate that
cohesin is required for mitotic aster formation in
vitro.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 8.
Quantification of aster assembly.
A, Western blot analysis of immunodepleted mitotic extracts.
Extracts were depleted with preimmune IgG (lane 1),
anti-hSMC1 (lane 2), and anti-hRAD21 (lane 3)
antibodies as indicated at the top. The degree of cohesin
depletion was checked by the presence of hSMC1 as indicated.
B, the efficiency of aster assembly. The immunodepleted
extracts from Fig. 8A were used to assemble asters in
vitro. The same volumes of reaction mixtures were placed on
coverslips and co-stained with anti- -tubulin and anti-NuMA
antibodies (see Fig. 9 legend). We examined 200 -tubulin-positive
NuMA spots and counted normal asters among them by randomly choosing
areas on the coverslip under the microscope. This was repeated three
times on multiple coverslips from two independent experiments. The
criteria for normal asters in this experiment are: 1) distinct
clustering of -tubulin at the center; 2) co-localization of
-tubulin with NuMA; and 3) at least four spindles emanating from the
aster in at least three different directions (see Fig. 9). Percentages
of normal asters were averaged with standard deviation and are shown in
the bar graph.
|
|

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 9.
Co-staining of asters with
anti- -tubulin and NuMA antibodies. Rabbit
anti-NuMA antibody (A and E) and mouse
anti- -tubulin antibody (C and G) were used for
co-staining as indicated at the top. Merged images are shown
(B, D, F, and H) with NuMA
in red, -tubulin in green, and overlap in
yellow. Upper panels are the assembly with
preimmune-depleted extract, and the lower panels are with an
anti-hRAD21-depleted extract as indicated on the left.
Because the -tubulin staining of the normal asters in the
preimmune-depleted extract assembly is so much brighter than that of
the irregular asters in the cohesin-depleted extract assembly, the
former image was exposed three times less than the latter to visualize
asters clearly. D and H show a higher
magnification of the individual asters indicated by white
arrows in B and F. H is
overexposed to visualize weak -tubulin and NuMA staining.
Scale bars are 10 µm in B and F, and
4 µm in D and H.
|
|
 |
DISCUSSION |
Although cohesin in both yeast and metazoans appears to play a
role in the establishment of sister chromatid cohesion after replication during S phase, there are differences regarding the timing
of cohesin dissociation from chromosomes and cohesin function during
mitosis. Namely, cohesin functions in sister chromatid cohesion until
the onset of anaphase in yeast, whereas a majority of it dissociates
from chromosomes prior to mitosis in metazoans. However, our previous
antibody microinjection studies suggested that hSMC1 is still involved
in the progression of mitosis, possibly in metaphase plate organization
in human mitotic cells (14). Does cytoplasmic cohesin, which no longer
interacts with chromosomes, play any role in mitotic chromosome
organization? Our current study demonstrates the mitosis-specific
localization of cohesin at the spindle poles and a specific interaction
between cohesin and NuMA, a factor critical for spindle organization.
Finally, we show that cohesin depletion inhibits mitotic spindle aster assembly in vitro. Based on these results, we propose that
cohesin may play an additional role in mitotic chromosome organization by acting on mitotic spindle structures.
Localization of Cohesin at the Mitotic Spindle Poles and the
Nuclear Matrix--
Analysis of the subcellular localization of a
protein by using immunofluorescent staining has often proven to be
valuable in deducing its potential function in the cell. It is
important, however, to utilize multiple antibodies because staining
patterns can vary significantly depending upon the antigen epitopes,
especially for large and/or highly structured proteins. Thus, our
criteria for determining specific protein localization are the
following. 1) Western blot analysis shows highly specific reactivity to
the target protein. 2) At least two different batches of antibodies exhibit the same staining pattern, preferably with antibodies against
different domains of the same protein. 3) If the protein is in a
complex, antibodies against other subunits exhibit the same staining
pattern; and finally, 4) the protein biochemically interacts with other
proteins that localize to the same place.
We first established the specificity of antibodies for the cohesin
components by Western analysis against the crude HeLa extracts. The
recent studies indicated that the non-SMC components of cohesin, SA1
and RAD21, localize to the interface between the two sister chromatids,
particularly the centromeric region, during metaphase (5, 15, 16).
However, our antibodies against all four cohesin components, including
the anti-hSMC1 antibody previously used for antibody microinjection
(14), failed to detect any specific localization of the endogenous
cohesin components in this location. Instead, we found that a
significant population of cohesin localizes to spindle poles. The
spindle pole localization of cohesin was confirmed by staining with
multiple antibodies against three of the cohesin subunits and was
antigen-specific. Interestingly, a previous report demonstrated that
hSMC1 interacts with hsHec1, which was shown to localize to the spindle
poles (37). Consistent with the spindle pole localization, we observed
in mitosis a strong interaction of cohesin with a subpopulation of
NuMA, the largest species that most likely represents the
mitosis-specific, hyperphosphorylated form (25, 26). Weaker
interactions of cohesin with dynein and -tubulin, which may be
indirectly mediated by NuMA, were also observed. Although our antibody
against hRAD21 failed to stain the mitotic spindle poles,
NuMA-coimmunoprecipitated hRAD21 from mitotic extracts and cohesin
depletion by an anti-hRAD21 antibody had a similar inhibitory effect on
mitotic aster assembly. Thus, the lack of staining is most likely due
to epitope inaccessibility of our antibody. Consistent with this
notion, hRad21 was recently observed at mitotic spindles using a
different antibody (16).
In interphase cells, sequential extraction revealed that not all
cohesin associates with DNA, but some is soluble while a third
population associates with the nuclear matrix. Dissociation of all four
cohesin components from chromosomes is initiated during G2
phase earlier than previously observed in a Xenopus system, which may be due to differences in cell cycling between somatic cells
and embryos (6). Consistent with the nuclear matrix association, the
interaction between cohesin and NuMA persists during interphase (25,
26). Although not well defined, the nuclear matrix has been implicated
in molecule transport as well as in a higher order chromosome
organization (31-33). Our results raise the interesting possibility
that cohesin-mediated chromosome organization may occur in the context
of the nuclear matrix. Consistent with this hypothesis, cohesin was
reported to play a role in establishing the boundary elements at the
HMR locus in S. cerevisiae (34). Boundary
elements are thought to exert their function by interacting with
the nuclear matrix (35, 36). Alternatively, the nuclear matrix-associated cohesin may constitute a separate population of
cohesin, which may be dedicated to participation in spindle organization in mitosis.
The Possible Role of Cohesin in Mitotic Spindle
Organization--
To determine the potential function of cohesin found
at the spindle apparatus, an in vitro aster assembly assay
was carried out using HeLa mitotic extracts. This assay was used
previously to demonstrate the function of proteins localized at the
spindle poles, such as NuMA, Eg5, and dynein in mitotic spindle
organization (18-20, 23). These results were validated by the in
vivo data in Xenopus (23). Using this assay, we
demonstrated that mitotic aster assembly was inhibited in a cohesin
depletion-specific manner. Aster assembly was inhibited by
immunodepletion with an antibody against hSMC1, hSMC3, SA1/SA2, or
hRAD21, but not with preimmune IgG, indicating that the cohesin complex
is involved in the assembly of mitotic asters. Although BRCA1 was shown
to localize to spindle poles and play an important role in centrosome
replication (29, 30), immunodepletion using anti-BRCA1 antibody did not
deplete cohesin and had no effect on mitotic spindle aster assembly,
indicating that the inhibition of aster formation is cohesin-specific
and not due to a nonspecific depletion effect of any protein at spindle poles. Furthermore, cohesin antibodies failed to co-deplete significant amounts of NuMA and -tubulin in our system, consistent with the fact
that only a subpopulation of NuMA and -tubulin interacts with
cohesin. This result indicates that the abolishment of aster assembly is not due to the lack of NuMA or -tubulin. This
idea is further supported by the observation that NuMA is still
associated with the irregularly shaped asters in the cohesin-depleted
assembly reactions, indicating that depletion of cohesin does not
affect NuMA localization. Rather, it is possible that cohesin is
recruited to the spindle poles by NuMA. Because -tubulin staining of
the irregular asters was much weaker, cohesin may be required for the
assembly or maintenance of spindles. This effect is specific to cohesin
and/or other factors that interact with and therefore are co-depleted
with cohesin. We have preliminary evidence that cohesin may interact in
a mitosis-specific manner with other factors that may be important
partners for the mitotic function of
cohesin.2 Further study is
necessary to investigate the NuMA-cohesin interaction as well as
whether cohesin interacts with other proteins important for mitotic
spindle organization, such as the component(s) of centrosomes and/or
pericentrosomal structures. Interestingly, the kinesin-related proteins
KIF3A and 3B and their associated protein SMAP were previously reported
to interact with hSMC3 (HCAP), also suggesting the potential function
of cohesin in the context of the microtubule network (38). Although
currently it is not clear how cohesin participates in mitotic spindle
aster assembly, our results indicate the multifunctionality of cohesin
in the cell.
 |
ACKNOWLEDGEMENTS |
We thank Drs. T. Hirano, T. Lindahl, and R. Shiekhattar for kindly providing antibodies for XRAD21, DNA ligase III,
and BRCA1, respectively. We thank Dr. C. Cooper for permission to call
SB1.8 hSMC1. We extend similar thanks to Dr. Y. Takai for permission to
refer to HCAP as hSMC3. We thank Dr. C. Hughes for use of a FACS
machine, and H. Liu, M. Nomura, and S. Sandmeyer for access to the
Zeiss microscope. We are grateful for critical reading of the
manuscript by Drs. B. Hamkalo, S. Sandmeyer, M. Nomura, R. Steele, M. Waterman, and A. Ball.
 |
FOOTNOTES |
*
This work was supported in part by a March of Dimes Basil
O'Connor Scholarship and National Institutes of Health Grant GM59150 (to K. Y.)The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Present address: Dept. of Pharmacology, Tohoku University School of
Medicine, 2-1 Seiryomachi Aobaku, Sendai 980-8575, Japan.
Formerly a Leukemia and Lymphoma Society Special Fellow and
currently a Scholar of the Leukemia and Lymphoma Society. To whom correspondence should be addressed. Dept. of Biological Chemistry, College of Medicine, 240D Med. Sci. I, University of California, Irvine, CA 92697-1700. Tel.: 949-824-8215; Fax: 949-824-2688; E-mail:
kyokomor@uci.edu.
Published, JBC Papers in Press, October 4, 2001, DOI 10.1074/jbc.M103364200
2
J. A. Schmiesing and K. Yokomori, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
SMC, structural maintenance of chromosomes;
SA1, stromal antigen 1;
SA2, stromal antigen 2;
hRAD21, human RAD21 protein;
hSMC, human SMC
protein;
NuMA, nuclear mitotic apparatus protein;
FACS, fluorescence-activated cell sorter;
SA1N, N-terminal domain of SA1;
SA1C, C-terminal domain of SA1;
SDS-PAGE, SDS-polyacrylamide gel
electrophoresis;
CSK, cytoskeleton;
Pipes, 1,4-piperazinediethanesulfonic acid;
DAPI, 4,6-diamidino-2-phenylindole.
 |
REFERENCES |
| 1.
|
Guacci, V.,
Koshland, D.,
and Strunnikov, A.
(1997)
Cell
91,
47-57[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Michaelis, C.,
Ciosk, R.,
and Nasmyth, K.
(1997)
Cell
91,
35-45[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Toth, A.,
Ciosk, R.,
Uhlmann, F.,
Galova, M.,
Schleiffer, A.,
and Nasmyth, K.
(1999)
Genes Dev.
13,
320-333[Abstract/Free Full Text]
|
| 4.
|
Nasmyth, K.,
Peters, J.-M.,
and Uhlmann, F.
(2000)
Science
288,
1379-1384[Abstract/Free Full Text]
|
| 5.
|
Losada, A.,
Yokochi, T.,
Kobayashi, R.,
and Hirano, T.
(2000)
J. Cell Biol.
150,
405-416[Abstract/Free Full Text]
|
| 6.
| Sumara, I., Vorlaufer, E., Gieffers, C., Peters, B. H., and
Peters, J.-M. (2000) J. Cell Biol.
|
| 7.
|
Tomonaga, T.,
Nagao, K.,
Kawasaki, Y.,
Furuya, K.,
Murakami, A.,
Morishita, J.,
Yuasa, T.,
Sutani, T.,
Kearsey, S. E.,
Uhlmann, F.,
Nasmyth, K.,
and Yanagida, M.
(2000)
Genes Dev.
14,
2757-2770[Abstract/Free Full Text]
|
| 8.
|
Birkenbihl, R. P.,
and Subramani, S.
(1992)
Nucleic Acids Res.
25,
6605-6611
|
| 9.
|
Uhlmann, F.,
Wernic, D.,
Poupart, M.-A.,
Koonin, E. V.,
and Nasmyth, K.
(2000)
Cell
103,
375-386[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Tanaka, T.,
Cosma, M. P.,
Wirth, K.,
and Nasmyth, K.
(1999)
Cell
98,
847-858[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Blat, Y.,
and Kleckner, N.
(1999)
Cell
98,
249-259[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Megee, P. C.,
Mistrot, C.,
Guacci, V.,
and Koshland, D.
(1999)
Mol. Cell
4,
445-450[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Losada, A.,
Hirano, M.,
and Hirano, T.
(1998)
Genes Dev.
12,
1986-1997[Abstract/Free Full Text]
|
| 14.
|
Schmiesing, J. A.,
Ball, A. R.,
Gregson, H. C.,
Alderton, J.,
Zhou, S.,
and Yokomori, K.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
12906-12911[Abstract/Free Full Text]
|
| 15.
|
Waizenegger, I. C.,
Hauf, S.,
Meinke, A.,
and Peters, J.-M.
(2000)
Cell
103,
399-410[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Hoque, M. T.,
and Ishikawa, F.
(2001)
J. Biol. Chem.
276,
5059-5067[Abstract/Free Full Text]
|
| 17.
|
Schmiesing, J. A.,
Gregson, H. C.,
Zhou, S.,
and Yokomori, K.
(2000)
Mol. Cell. Biol.
20,
6996-7006[Abstract/Free Full Text]
|
| 18.
|
Gaglio, T.,
Dionnne, M. A.,
and Compton, D. A.
(1997)
J. Cell Biol.
138,
1055-1066[Abstract/Free Full Text]
|
| 19.
|
Gaglio, T.,
Saredi, A.,
Bingham, J. B.,
Hasbani, M. J.,
Gill, S. R.,
Schroer, T. A.,
and Compton, D. A.
(1996)
J. Cell Biol.
135,
399-414[Abstract/Free Full Text]
|
| 20.
|
Gaglio, T.,
Saredi, A.,
and Compton, D. A.
(1995)
J. Cell Biol.
131,
693-708[Abstract/Free Full Text]
|
| 21.
|
Nomura, N.,
Nagase, T.,
Miyajima, N.,
Sazuka, T.,
Tanaka, A.,
Sato, S.,
Seki, N.,
Kawarabayashi, Y.,
Ishikawa, K.,
and Tabata, S.
(1994)
DNA Res.
1,
223-229[Abstract]
|
| 22.
|
Jessberger, R.,
Riwar, B.,
Baechtold, H.,
and Akhmedov, A. T.
(1996)
EMBO J.
15,
4061-4068[Medline]
[Order article via Infotrieve]
|
| 23.
|
Merdes, A.,
Ramyar, K.,
Vechio, J. D.,
and Cleveland, D. W.
(1996)
Cell
87,
447-458[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Merdes, A.,
Heald, R.,
Samejima, K.,
Earnshaw, W. C.,
and Cleveland, D. W.
(2000)
J. Cell Biol.
149,
851-861[Abstract/Free Full Text]
|
| 25.
|
Hsu, H.-L.,
and Yeh, N.-H.
(1996)
J. Cell Sci.
109,
277-288[Abstract]
|
| 26.
|
Compton, D. A.,
and Luo, C.
(1995)
J. Cell Sci.
108,
621-633[Abstract]
|
| 27.
|
Lydersen, B. K.,
and Pettijohn, D. E.
(1980)
Cell
22,
489-499[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Fey, E. G.,
Wan, K. M.,
and Penman, S.
(1984)
J. Cell Biol.
98,
1973-1984[Abstract/Free Full Text]
|
| 29.
|
Hsu, L. C.,
and White, R. L.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
12983-12988[Abstract/Free Full Text]
|
| 30.
|
Xu, X.,
Weaver, Z.,
Linke, S. P.,
Li, C.,
Gotay, J.,
Wang, X. W.,
Harris, C. C.,
Ried, T.,
and Deng, C. X.
(1999)
Mol. Cell
3,
389-395[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
de Belle, I.,
Cai, S.,
and Kohwi-Shigematsu, T.
(1998)
J. Cell Biol.
141,
335-348[Abstract/Free Full Text]
|
| 32.
|
Pederson, T.
(2000)
Mol. Biol. Cell
11,
799-805[Abstract/Free Full Text]
|
| 33.
|
Zhao, K.,
Wang, W.,
Rando, O. J.,
Xue, Y.,
Swiderek, K.,
Kuo, A.,
and Crabtree, G. R.
(1998)
Cell
95,
625-636[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Donze, D.,
Adams, C. R.,
Rine, J.,
and Kamakaka, R. T.
(1999)
Genes Dev.
13,
698-708[Abstract/Free Full Text]
|
| 35.
|
Gerasimova, T. I.,
and Corces, V. G.
(1998)
Cell
92,
511-521[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Udvardy, A.
(1999)
EMBO J.
18,
1-8[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Zheng, L.,
Chen, Y.,
and Lee, W.-H.
(1999)
Mol. Cell. Biol.
19,
5417-5428[Abstract/Free Full Text]
|
| 38.
|
Shimizu, K.,
Shirataki, H.,
Honda, T.,
Minami, S.,
and Takai, Y.
(1998)
J. Biol. Chem.
273,
6591-6594[Abstract/Free Full Text]
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X. Kong, S. K. Mohanty, J. Stephens, J. T. Heale, V. Gomez-Godinez, L. Z. Shi, J.-S. Kim, K. Yokomori, and M. W. Berns
Comparative analysis of different laser systems to study cellular responses to DNA damage in mammalian cells
Nucleic Acids Res.,
May 1, 2009;
37(9):
e68 - e68.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Kong, A. R. Ball Jr., E. Sonoda, J. Feng, S. Takeda, T. Fukagawa, T. J. Yen, and K. Yokomori
Cohesin Associates with Spindle Poles in a Mitosis-specific Manner and Functions in Spindle Assembly in Vertebrate Cells
Mol. Biol. Cell,
March 1, 2009;
20(5):
1289 - 1301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Wong and G. Blobel
Cohesin subunit SMC1 associates with mitotic microtubules at the spindle pole
PNAS,
October 7, 2008;
105(40):
15441 - 15445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Stanvitch and L. L. Moore
cin-4, a Gene With Homology to Topoisomerase II, Is Required for Centromere Resolution by Cohesin Removal From Sister Kinetochores During Mitosis
Genetics,
January 1, 2008;
178(1):
83 - 97.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Parish, J. Rosa, X. Wang, J. M. Lahti, S. J. Doxsey, and E. J. Androphy
The DNA helicase ChlR1 is required for sister chromatid cohesion in mammalian cells
J. Cell Sci.,
December 1, 2006;
119(23):
4857 - 4865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Assmann, M. R. Alborghetti, M. E. R. Camargo, and J. Kobarg
FEZ1 Dimerization and Interaction with Transcription Regulatory Proteins Involves Its Coiled-coil Region
J. Biol. Chem.,
April 14, 2006;
281(15):
9869 - 9881.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Jia, L. Barbier, H. Stuart, M. Amraei, S. Pelech, J. W. Dennis, P. Metalnikov, P. O'Donnell, and I. R. Nabi
Tumor Cell Pseudopodial Protrusions: LOCALIZED SIGNALING DOMAINS COORDINATING CYTOSKELETON REMODELING, CELL ADHESION, GLYCOLYSIS, RNA TRANSLOCATION, AND PROTEIN TRANSLATION
J. Biol. Chem.,
August 26, 2005;
280(34):
30564 - 30573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-S. Kim, T. B. Krasieva, H. Kurumizaka, D. J. Chen, A. M. R. Taylor, and K. Yokomori
Independent and sequential recruitment of NHEJ and HR factors to DNA damage sites in mammalian cells
J. Cell Biol.,
August 1, 2005;
170(3):
341 - 347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. S. Lam, X. Yang, and C. A. Makaroff
Characterization of Arabidopsis thaliana SMC1 and SMC3: evidence that AtSMC3 may function beyond chromosome cohesion
J. Cell Sci.,
July 15, 2005;
118(14):
3037 - 3048.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-C. Huang, R. Jagadeeswaran, E. S. Liu, and E. J. Benz Jr.
Protein 4.1R, a Microtubule-associated Protein Involved in Microtubule Aster Assembly in Mammalian Mitotic Extract
J. Biol. Chem.,
August 13, 2004;
279(33):
34595 - 34602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Geiman, U. T. Sankpal, A. K. Robertson, Y. Chen, M. Mazumdar, J. T. Heale, J. A. Schmiesing, W. Kim, K. Yokomori, Y. Zhao, et al.
Isolation and characterization of a novel DNA methyltransferase complex linking DNMT3B with components of the mitotic chromosome condensation machinery
Nucleic Acids Res.,
May 17, 2004;
32(9):
2716 - 2729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Parra, A. Viera, R. Gomez, J. Page, R. Benavente, J. L. Santos, J. S. Rufas, and J. A. Suja
Involvement of the cohesin Rad21 and SCP3 in monopolar attachment of sister kinetochores during mouse meiosis I
J. Cell Sci.,
March 1, 2004;
117(7):
1221 - 1234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. P. Bermudez, Y. Maniwa, I. Tappin, K. Ozato, K. Yokomori, and J. Hurwitz
The alternative Ctf18-Dcc1-Ctf8-replication factor C complex required for sister chromatid cohesion loads proliferating cell nuclear antigen onto DNA
PNAS,
September 2, 2003;
100(18):
10237 - 10242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-S. Kim, T. B. Krasieva, V. LaMorte, A. M. R. Taylor, and K. Yokomori
Specific Recruitment of Human Cohesin to Laser-induced DNA Damage
J. Biol. Chem.,
November 15, 2002;
277(47):
45149 - 45153.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|